Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)
Alchemist includes several clinical trials. Their goal is to test new therapies for patients like you: those with early stage non-small cell lung cancer whose tumor can be surgically removed. Some of the ALCHEMIST trials are seeking patients with specific mutations, or changes, in their cancer tumors. These changes are relatively rare: they exist in about 10 percent or less of all tumors. If your tumor has these changes, you may be given a new type of medicine called “targeted therapy.” These medicines are developed to “target,” or attack the changes in your tumor and prevent the cancer from returning. If your tumor does not have a specific mutation or change to the gene, you may have an opportunity to enroll in another ALCHEMIST study and receive an “immunotherapy” medicine that may help your own immune system prevent the cancer from returning.
Condition | Lung Cancer |
---|---|
Clinical Study Identifier | TX149717 |
Last Modified on | 3 December 2020 |
,
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.